In March 2025, the company introduced new programs for the immediate-to-purchaser presenting of its Wegovy weight loss drug. The company recognized a fresh pharmacy, named NovoCare, which might cost prospects $499 each month for entry to the drug, lower than 50 percent the expense of the drug through other pharmaceutical distribution networks.[53]P